Company: EDSA
Filing Date: 2025-09-09
Form Type: 424B5
Source: 0001171843-25-005799
Chunk: 4

Company: Edesa Biotech, Inc.
Filing Date: 2025-09-09
Form: 424B5
Chunk 4
---
 where it is lawful to do so. We are not
making offers to sell or solicitations to buy our securities in any jurisdiction in which an offer or solicitation is not authorized or
in which the person making that offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or
solicitation.

If information in this prospectus supplement
is inconsistent with the accompanying base prospectus or the information incorporated by reference with an earlier date, you should rely
on this prospectus supplement. This prospectus supplement, together with the accompanying base prospectus and the documents incorporated
by reference into this prospectus supplement and the accompanying base prospectus, include all material information relating to this offering.
You should assume that the information appearing in this prospectus supplement, the accompanying base prospectus and the documents incorporated
by reference in this prospectus supplement and the accompanying base prospectus is accurate only as of the respective dates of those documents.
Our business, financial condition, results of operations and prospects may have changed since those dates. You should carefully read this prospectus supplement, the accompanying base prospectus and the information and documents incorporated by reference herein and therein before making an investment decision. See “ Where You Can Find More Information” in this prospectus supplement and in the accompanying base prospectus.

We have not, and Wainwright has not,
authorized anyone to provide you with information that is different from that contained in this prospectus supplement, the accompanying
base prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. When you make a decision
about whether to invest in our securities, you should not rely upon any information other than the information contained in or incorporated
by reference into this prospectus supplement, the accompanying base prospectus or in any free writing prospectus that we may authorize
to be delivered or made available to you. Neither the delivery of this prospectus supplement and the accompanying base prospectus nor
the sale of our securities means that the information contained in this prospectus supplement, the accompanying base prospectus or any
free writing prospectus is correct after the date of the respective dates of such documents.

For investors outside the United States:
We have not, and Wainwright has not, taken any action that would permit this offering or possession or distribution of this prospectus
supplement or the accompanying base prospectus in any jurisdiction where action for that purpose is required, other than in the United
States. Persons outside the United States who